loadpatents
name:-0.022240161895752
name:-0.014708042144775
name:-0.0011670589447021
Nakao; Kazuwa Patent Filings

Nakao; Kazuwa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nakao; Kazuwa.The latest application filed is for "method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease".

Company Profile
0.16.14
  • Nakao; Kazuwa - Kyoto-shi JP
  • Nakao; Kazuwa - Kyoto N/A JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for increasing body height comprising systemic administration of CNP-53
Grant 8,815,803 - Nakao , et al. August 26, 2
2014-08-26
Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes
Grant 8,658,373 - Nakao , et al. February 25, 2
2014-02-25
Method Of Examining Polycystic Kidney Disease And Method Of Screening For Therapeutic Agent Of The Disease
App 20130225443 - Osafune; Kenji ;   et al.
2013-08-29
Method Of Treating Arthritis And Promoting Growth Of Articular Chondrocytes
App 20100209958 - Nakao; Kazuwa ;   et al.
2010-08-19
Method of treating arthritis and promoting growth of articular chondrocytes
Grant 7,642,243 - Nakao , et al. January 5, 2
2010-01-05
Method for differentiating primate embryonic stem cell into vascular cell
Grant 7,572,630 - Nakao , et al. August 11, 2
2009-08-11
Composition for Increasing Body Height
App 20080312142 - Nakao; Kazuwa ;   et al.
2008-12-18
Human endothelin receptor
Grant 7,452,970 - Imura , et al. November 18, 2
2008-11-18
Human endothelin receptor
App 20080119638 - Imura; Hiroo ;   et al.
2008-05-22
Method Of Producing Vascular Endothelial Cells From Primate Embryonic Stem Cells
App 20080025955 - Nakao; Kazuwa ;   et al.
2008-01-31
Theurapeutic or prophyiactic agent for arthritis
App 20070197434 - Nakao; Kazuwa ;   et al.
2007-08-23
Method for differentiating primate embryonic stem cell into vascular cell
App 20050191744 - Nakao, Kazuwa ;   et al.
2005-09-01
Rheumatoid arthritis autoantigen polypeptides
App 20040253644 - Osaki, Shoichi ;   et al.
2004-12-16
Diagnostic drugs for autoimmune diseases
Grant 6,822,078 - Ozaki , et al. November 23, 2
2004-11-23
Human endothelin receptor
Grant 6,821,743 - Imura , et al. November 23, 2
2004-11-23
Diagnostic drugs for autoimmune diseases
App 20040229279 - Ozaki, Shoichi ;   et al.
2004-11-18
Therapeutic agents for achondroplasia
App 20040198665 - Nakao, Kazuwa
2004-10-07
Therapeutic agents for achondroplasia
Grant 6,743,425 - Nakao June 1, 2
2004-06-01
Therapeutic agents for achondroplasia
App 20030068313 - Nakao, Kazuwa
2003-04-10
Human endothelin receptor
App 20020082414 - Imura, Hiroo ;   et al.
2002-06-27
Diagnostic Drugs For Autoimmune Diseases
App 20020009749 - OZAKI, SHOICHI ;   et al.
2002-01-24
Human endothelin receptor
Grant 6,313,276 - Imura , et al. November 6, 2
2001-11-06
Monoclonal antibody recognizing atrial natriuretic polypeptide
Grant 5,124,264 - Imura , et al. June 23, 1
1992-06-23
Polypeptide relating to .alpha.-hANP
Grant 4,673,732 - Kiso , et al. June 16, 1
1987-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed